HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karin N Westlund Selected Research

Inflammation (Inflammations)

9/2023Epigenetic HDAC5 Inhibitor Reverses Craniofacial Neuropathic Pain in Mice.
11/2022Peroxisome proliferator-activated receptor gamma agonist ELB00824 suppresses oxaliplatin-induced pain, neuronal hypersensitivity, and oxidative stress.
3/2021Effect of acetyl-L-carnitine on hypersensitivity in acute recurrent caerulein-induced pancreatitis and microglial activation along the brain's pain circuitry.
5/2017Disulfide high mobility group box-1 causes bladder pain through bladder Toll-like receptor 4.
1/2016Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1.
1/2015Macrophage Migration Inhibitory Factor Mediates PAR-Induced Bladder Pain.
11/2014Cannabinoid receptor 2 agonist attenuates pain related behavior in rats with chronic alcohol/high fat diet induced pancreatitis.
8/2012Gene expression profiling and endothelin in acute experimental pancreatitis.
7/2012Chronic inflammation and pain in a tumor necrosis factor receptor (TNFR) (p55/p75-/-) dual deficient murine model.
8/2010Impact of central and peripheral TRPV1 and ROS levels on proinflammatory mediators and nociceptive behavior.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karin N Westlund Research Topics

Disease

28Pain (Aches)
01/2024 - 02/2003
20Inflammation (Inflammations)
09/2023 - 01/2000
14Neuralgia (Stump Neuralgia)
09/2023 - 08/2012
12Hypersensitivity (Allergy)
11/2022 - 07/2012
10Pancreatitis
03/2021 - 02/2003
6Chronic Pain
07/2023 - 01/2017
6Hyperalgesia
11/2022 - 01/2002
5Arthritis (Polyarthritis)
01/2013 - 01/2000
4Trigeminal Nerve Injuries
07/2023 - 01/2018
4Visceral Pain
03/2018 - 02/2003
4Tics (Tic)
01/2018 - 01/2016
3Chronic Pancreatitis
11/2014 - 02/2003
3Joint Diseases (Joint Disease)
01/2013 - 09/2005
2Neoplasms (Cancer)
09/2006 - 09/2005
1Demyelinating Diseases (Demyelinating Disease)
08/2023
1Trigeminal Neuralgia (Tic Douloureux)
08/2023
1Acute Pain
08/2023
1Intractable Pain
08/2023
1Back Pain (Backache)
01/2023
1Low Back Pain (Lumbago)
01/2023
1Colonic Neoplasms (Colon Cancer)
11/2022
1Mouth Neoplasms (Oral Cancer)
11/2022
1Spontaneous Remission
03/2021
1Atrophy
03/2021
1Fibrosis (Cirrhosis)
03/2021
1Neuroblastoma
01/2020
1Experimental Arthritis
01/2020

Drug/Important Bio-Agent (IBA)

6Opioid Analgesics (Opioids)IBA
07/2023 - 09/2004
5Glutamic Acid (Glutamate)FDA Link
01/2020 - 01/2000
5Morphine (MS Contin)FDA LinkGeneric
01/2015 - 02/2003
4Proteins (Proteins, Gene)FDA Link
09/2023 - 01/2015
3N-Methylaspartate (NMDA)IBA
08/2023 - 01/2018
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
08/2023 - 03/2003
3Pioglitazone (Actos)FDA Link
11/2022 - 12/2017
3PPAR gammaIBA
11/2022 - 12/2017
3Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
01/2015 - 01/2000
3Complementary DNA (cDNA)IBA
08/2012 - 10/2007
3EnkephalinsIBA
03/2008 - 10/2007
2Histone Deacetylases (Histone Deacetylase)IBA
09/2023 - 01/2018
2NeuropeptidesIBA
01/2023 - 02/2003
2ELB00824IBA
11/2022 - 03/2020
2PPAR-gamma AgonistsIBA
11/2022 - 01/2019
2Peptides (Polypeptides)IBA
12/2021 - 01/2016
2CeruletideIBA
03/2021 - 01/2004
2salicylhydroxamic acid (SHAM)IBA
01/2018 - 08/2012
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2018 - 12/2017
2protease-activated receptor 4IBA
05/2017 - 01/2016
2HMGB1 Protein (HMG1)IBA
05/2017 - 01/2016
2Macrophage Migration-Inhibitory FactorsIBA
01/2016 - 01/2015
2preproenkephalinIBA
01/2016 - 02/2008
2Analgesics (Analgesic Drugs)IBA
11/2014 - 09/2004
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
07/2012 - 06/2009
2Type I Tumor Necrosis Factor ReceptorsIBA
07/2012 - 06/2009
2CarrageenanIBA
08/2010 - 01/2002
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2010 - 06/2009
2KaolinIBA
08/2010 - 01/2002
2CalciumIBA
08/2009 - 09/2006
2Protons (Proton)IBA
06/2009 - 09/2005
2beta-Galactosidase (Lactaid)IBA
02/2008 - 10/2007
2dibutyldichlorotinIBA
10/2007 - 02/2003
2BradykininIBA
09/2004 - 03/2003
2Excitatory Amino Acid AntagonistsIBA
01/2004 - 03/2003
1Formaldehyde (Formol)FDA Link
01/2024
1Dihydrotachysterol (AT 10)IBA
09/2023
1Growth Hormone (Somatotropin)IBA
09/2023
1RNA (Ribonucleic Acid)IBA
09/2023
1SirtuinsIBA
09/2023
1Anticonvulsants (Antiepileptic Drugs)IBA
08/2023
1Glutamate Receptors (Glutamate Receptor)IBA
08/2023
1Cholecystokinin B ReceptorIBA
07/2023
1Cholecystokinin (Pancreozymin)IBA
07/2023
1Serine Proteases (Serine Protease)IBA
01/2023
1Dynorphins (Dynorphin)IBA
01/2023
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2023
1Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2022
1Antineoplastic Agents (Antineoplastics)IBA
11/2022
1Dry IceIBA
11/2022
1Transcription Factors (Transcription Factor)IBA
11/2022
1Single-Chain AntibodiesIBA
12/2021
1AntibodiesIBA
12/2021
1Calcium Channels (Calcium Channel)IBA
12/2021
1T-Type Calcium Channels (T-Type Calcium Channel)IBA
12/2021
1Fast GreenIBA
03/2021
1Acetylcarnitine (Alcar)IBA
03/2021
1ManganeseIBA
12/2020
1lavendustin BIBA
01/2020
1daidzeinIBA
01/2020
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2020
1lavendustin AIBA
01/2020
1Tyrosine Kinase InhibitorsIBA
01/2020
1NR1 NMDA receptorIBA
01/2020
1GenisteinIBA
01/2020

Therapy/Procedure

8Therapeutics
08/2023 - 03/2003
4Intraperitoneal Injections
12/2021 - 01/2004
3Analgesia
11/2014 - 03/2008
2Sutures (Suture)
05/2020 - 12/2012
2Aftercare (After-Treatment)
01/2020 - 01/2015
1Drug Therapy (Chemotherapy)
11/2022
1Injections
03/2021
1Oral Surgery (Maxillofacial Surgery)
04/2020